Valuation Zai Lab Limited Hong Kong S.E.

Stocks

Market Closed - Hong Kong S.E. Other stock markets 04:08:21 2026-06-12 EDT			5-day change	1st Jan Change
13.18 ^HKD	-1.27%		+4.60%	-3.44%

06-10	Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading	MT
06-09	Zai Lab Says China Approves Tivdak for Cervical Cancer Treatment	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	6,059	2,946	2,688	2,853	1,962	1,918	-	-
Change	-	-51.37%	-8.77%	6.15%	-31.23%	-2.24%	-	-
Enterprise Value (EV) ¹	4,650	1,938	1,897	2,095	1,397	1,475	1,531	1,703
Change	-	-58.33%	-2.13%	10.47%	-33.34%	5.6%	3.79%	11.29%
P/E Ratio	-8.29x	-6.63x	-7.9x	-10.1x	-11x	-7.71x	-9.15x	-12.7x
PBR	4.35x	-	3.34x	3.36x	2.73x	3.59x	3.86x	3.82x
PEG	-	0.2x	0.3x	0.4x	0.3x	-0.2x	0.6x	0.5x
Capitalization / Revenue	42x	13.7x	10.1x	7.15x	4.26x	4.27x	3.22x	2.54x
EV / Revenue	32.2x	9.01x	7.11x	5.25x	3.04x	3.29x	2.57x	2.25x
EV / EBITDA	-6.7x	-4.89x	-5.3x	-7.75x	-6.51x	-6.07x	-9.57x	-25.6x
EV / EBIT	-6.64x	-4.79x	-5.17x	-7.43x	-6.09x	-5.7x	-8.81x	-19.8x
EV / FCF	-8.19x	-4.94x	-9.23x	-9.5x	-8.5x	-8.39x	-13.2x	-24.3x
FCF Yield	-12.2%	-20.2%	-10.8%	-10.5%	-11.8%	-11.9%	-7.57%	-4.12%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-7.58	-4.63	-3.46	-2.6	-1.6	-2.215	-1.865	-1.347
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	144.3	215	266.7	399	460.2	448.7	595.6	755.9
EBITDA ¹	-693.6	-396.1	-357.5	-270.3	-214.4	-243	-159.9	-66.57
EBIT ¹	-700.1	-404.4	-366.6	-282.1	-229.4	-258.7	-173.7	-85.83
Net income ¹	-704.5	-443.3	-334.6	-257.1	-175.5	-240.9	-156.5	-125.8
Net Debt ¹	-1,409	-1,008	-791.3	-757.9	-565.3	-443.1	-387.2	-214.4
Reference price ²	62.85	30.70	27.33	26.19	17.64	17.07	17.07	17.07
Nbr of stocks (in thousands)	96,409	95,972	98,349	108,937	111,219	112,355	-	-
Announcement Date	3/1/22	3/1/23	2/27/24	2/27/25	2/26/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REGENERON PHARMACEUTICALS, INC.	15.85x	3.42x	9.24x	0.64%	62.28B
UCB	29.67x	6x	17.19x	0.53%	60.59B
SAMSUNG BIOLOGICS CO.,LTD.	32.01x	10.82x	20.41x	-.--%	39.55B
CSL LIMITED	-48.72x	2.97x	8.76x	3.76%	36.8B
BIOGEN INC.	32.3x	3.5x	10.57x	-.--%	29.53B
INCYTE CORPORATION	16.54x	2.97x	9.18x	-.--%	21.68B
MODERNA, INC.	-5.77x	7.76x	-4.74x	-.--%	19.8B
INNOVENT BIOLOGICS, INC.	49.09x	5.22x	37.5x	-.--%	16.96B
SWEDISH ORPHAN BIOVITRUM AB	24.58x	5.09x	13.72x	-.--%	16.16B
Average	16.17x	5.30x	13.54x	0.55%	33.71B
Weighted average by Cap.	15.45x	5.29x	13.26x	0.69%